Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$27,000.00

The dynamics and impact of IL-2 and IL-15 cytokines on the development of CD8 T cell exhaustion and their role in cancer control

EF 2024-25

Résumé
Immunotherapies have significantly improved survival for patients with refractory or metastatic cancers. However, optimizing these treatments requires enhancing the immune response, especially the function of CD8 T lymphocytes, which are essential in fighting cancer. A subtype of these cells, progenitor T cells , is crucial for the effectiveness of immunotherapies. When these cells become exhausted, they lose their ability to combat tumors. Thus, understanding how their inflammatory environment influences differentiation and function is essential. Dr. Decaluwe lab has shown that cytokines IL-2 and IL-15 play a key role in regulating exhausted T cells. These cytokines share the IL2RB receptor to transmit their signals. Blocking this receptor promotes T development and improves tumor control. We hypothesize that IL-2 and IL-15 may have distinct roles in T cell differentiation. This project aims to better understand these differences and develop specific therapeutic strategies. The objectives are: (1)analyze IL-2 and IL-15 expression in T cell exhaustion models, (2)assess the synergy or redundancy of these cytokines, and (3)identify the optimal timing to block their signaling to promote T and enhance cancer treatment efficacy. Murine models of chronic viral infection and melanoma will be used to study the kinetic of cytokine secretion during T cell exhaustion. IL-2 and IL-15 levels will be measured in the blood and lymphoid organs at different time points. The expression of their receptors will be studied using spectral cytometry. Transgenic mice with modified IL2R a or IL-2RB genes or incapable of producing IL-15 will evaluate different cytokine inhibition scenarios. The results could lead to new therapeutic strategies to improve cancer immunotherapies.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530188
Name
Ballestero Vidal Arnau
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The dynamics and impact of IL-2 and IL-15 cytokines on the development of CD8 T cell exhaustion and their role in cancer control
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cd8 T Cell Exhaustion; Chronic Viral Infections; Cytokines; Il-15; Il-2; Il2rb Receptor; Immunotherapies; Lcmv; Tprog
Abstract
Immunotherapies have significantly improved survival for patients with refractory or metastatic cancers. However, optimizing these treatments requires enhancing the immune response, especially the function of CD8 T lymphocytes, which are essential in fighting cancer. A subtype of these cells, progenitor T cells , is crucial for the effectiveness of immunotherapies. When these cells become exhausted, they lose their ability to combat tumors. Thus, understanding how their inflammatory environment influences differentiation and function is essential. Dr. Decaluwe lab has shown that cytokines IL-2 and IL-15 play a key role in regulating exhausted T cells. These cytokines share the IL2RB receptor to transmit their signals. Blocking this receptor promotes T development and improves tumor control. We hypothesize that IL-2 and IL-15 may have distinct roles in T cell differentiation. This project aims to better understand these differences and develop specific therapeutic strategies. The objectives are: (1)analyze IL-2 and IL-15 expression in T cell exhaustion models, (2)assess the synergy or redundancy of these cytokines, and (3)identify the optimal timing to block their signaling to promote T and enhance cancer treatment efficacy. Murine models of chronic viral infection and melanoma will be used to study the kinetic of cytokine secretion during T cell exhaustion. IL-2 and IL-15 levels will be measured in the blood and lymphoid organs at different time points. The expression of their receptors will be studied using spectral cytometry. Transgenic mice with modified IL2R a or IL-2RB genes or incapable of producing IL-15 will evaluate different cytokine inhibition scenarios. The results could lead to new therapeutic strategies to improve cancer immunotherapies.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ballestero Vidal, Arnau
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~